What is CVE-2023-3717?

CVE-2023-3717 is a critical-severity vulnerability in Farmakom Remote Administration Console, classified under SQL Injection. CVSS score: 9.8/10. Published 2023-08-08.

How severe is CVE-2023-3717?

Critical severity. CVSS v3 base score is 9.8 out of 10.

Is CVE-2023-3717 known to be exploited?

1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.

SQL Injection in Farmakom Remote Administration Console

CVE-2023-3717

Improper Neutralization of Special Elements used in an SQL Command ('SQL Injection') vulnerability in Farmakom Remote Administration Console allows SQL Injection. This issue affects Remote Administration Console: before 1.02.

Vulnerability class: SQL Injection

EPSS: 0.006 (47.3th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 9.8 (Critical). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.

Affected products

Farmakom Remote Administration Console — versions 0
Farmakom Remote_administration_console

Weakness classification (CWE)

CWE-89 — SQL Injection

Public proof-of-concept exploits

fkie-cad/nvd-json-data-feeds

References

iletisim@usom.gov.tr (Third Party Advisory, government-resource, broken-link)
iletisim@usom.gov.tr (government-resource)

Frequently asked questions

What is CVE-2023-3717?: CVE-2023-3717 is a critical-severity vulnerability in Farmakom Remote Administration Console, classified under SQL Injection. CVSS score: 9.8/10. Published 2023-08-08.
How severe is CVE-2023-3717?: Critical severity. CVSS v3 base score is 9.8 out of 10.
Is CVE-2023-3717 known to be exploited?: 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.